There is significant uncertainty surrounding the healthcare system’s future in 2017 under a Republican Congress and President, but it’s unlikely that the Affordable Care Act will be repealed without some replacement that accommodates the individuals newly covered by it, said Robert W. Carlson, MD, CEO of the National Comprehensive Cancer Network.
There is significant uncertainty surrounding the healthcare system’s future in 2017 under a Republican Congress and President, but it’s unlikely that the Affordable Care Act will be repealed without some replacement that accommodates the individuals newly covered by it, said Robert W. Carlson, MD, CEO of the National Comprehensive Cancer Network.
Transcript (slightly modified)
What are some forces that will drive the transformation of healthcare in 2017?
Well, this interview is being taped just 1 week after the presidential election, so I think that the major uncertainty about what’s going to drive healthcare over the next year actually relates to the Trump administration and the Republican Congress and Senate, and what components of the Affordable Care Act they maintain or repeal. The early information is that they will repeal the Affordable Care Act, but it’s hard for me as a clinician to believe that they would do that without replacing it with something that assured the care of the 20 million people that the Affordable Care Act has extended insurance to, and also without being sure that those individuals for whom healthcare has been extended, or coverage has been extended, such as those with pre-existing conditions or the children under 26 years of age, that there wouldn’t be some system of accommodating and caring for those individuals.
But I think this is going to be a year of transition, it sounds like it’s going to be a big year of uncertainty in healthcare because of the early statements that are coming out about how the Republican administration is likely to modify the national insurance coverage.
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Contributor: More Informed Management of Preeclampsia Is Necessary
November 29th 2023At present, it is difficult for clinicians to identify patients at greatest risk for developing preeclampsia with severe features and tailor treatment plans for them; this difficulty increases costs significantly.
Read More